Keymed Biosciences Inc. (02162): February 2026 Monthly Securities Movement Update
Bulletin Express
Yesterday
Keymed Biosciences Inc. announced that as of February 28, 2026, authorized share capital remained at 500.00 million shares, each with a par value of USD 0.0001, totaling USD 0.05 million in authorized capital. The issued share count was 298.74 million shares, unchanged from the previous month.
No share options, warrants, convertibles, or other arrangements were disclosed. The company confirmed compliance with the minimum public float requirement, which stands at 25% of the issued shares (excluding any treasury shares). The information was submitted on March 2, 2026, by the company’s executive director.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.